Los Angeles Capital Management LLC Artivion, Inc. Transaction History

Los Angeles Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$15.73 - $22.91 $88,072 - $128,273	-5,599 Reduced 33.08%	11,326 $214,000
Q1 2022 May 06, 2022	SELL	$16.95 - $21.74 $13,560 - $17,392	-800 Reduced 4.51%	16,925 $362,000
Q4 2021 Feb 03, 2022	SELL	$17.19 - $22.84 $2,492 - $3,311	-145 Reduced 0.81%	17,725 $361,000
Q3 2021 Nov 08, 2021	BUY	$22.29 - $28.7 $891 - $1,148	40 Added 0.22%	17,870 $398,000
Q2 2021 Aug 05, 2021	BUY	$22.32 - $32.07 $188,380 - $270,670	8,440 Added 89.88%	17,830 $506,000
Q1 2021 May 05, 2021	SELL	$22.07 - $26.31 $145,993 - $174,040	-6,615 Reduced 41.33%	9,390 $212,000
Q4 2020 Feb 04, 2021	BUY	$16.76 - $23.74 $268,243 - $379,958	16,005 New	16,005 $378,000

176

37.1M

29.9K

2.3K

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $974M
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.